comparison of the effects of escitalopram and fluoxetine on cognitive condition in the stroke patients

comparison of the therapeutic effects of escitalopram and fluoxetine on cognitive function in the ischemic stroke patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211114053059N1

Enrollment

Registered

2021-11-23

Start date

2021-12-15

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke.

Interventions

Intervention 1: Intervention group: receiving escitalpram. Intervention 2: Intervention group: receiving fluoxetine.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: confirmed ischemic stroke consent on enrollment

Exclusion criteria

Exclusion criteria: major depression patients having no history of the aforementioned drug

Design outcomes

Primary

Measure	Time frame
Dementia Rating Scale. Timepoint: 5th and 90th day after diagnosis. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMilad Salehi

Oroumia University of Medical Sciences

Miladsalehi32@gmail.com+98 44 3345 9423

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026